Health Care & Life Sciences » Pharmaceuticals | Guizhou Xinbang Pharmaceutical Co. Ltd.

Guizhou Xinbang Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
563
2,464
4,158
5,131
5,974
6,549
Cost of Goods Sold (COGS) incl. D&A
220
1,856
3,359
4,097
4,825
5,260
Gross Income
343
608
800
1,035
1,149
1,288
SG&A Expense
296
370
500
689
659
841
EBIT
47
234
292
407
490
1,090
Non Operating Income/Expense
3
6
1
3
9
14
Interest Expense
17
75
126
132
108
152
Pretax Income
48
199
228
312
419
1,211
Income Tax
8
45
60
69
88
72
Consolidated Net Income
40
154
168
243
331
1,283
Net Income
40
145
174
246
319
1,297
Net Income After Extraordinaries
40
145
174
246
319
1,297
Net Income Available to Common
40
145
174
246
319
1,297
EPS (Basic)
0.05
0.13
0.14
0.15
0.19
0.78
Basic Shares Outstanding
868
1,131
1,251
1,640
1,705
1,667
EPS (Diluted)
0.05
0.13
0.14
0.15
0.19
0.78
Diluted Shares Outstanding
868
1,131
1,251
1,640
1,705
1,667
EBITDA
67
290
423
546
671
857
Other Operating Expense
1
3
8
62
-
1,537
Non-Operating Interest Income
6
15
18
33
28
18
Minority Interest Expense
1
9
6
3
12
13

About Guizhou Xinbang Pharmaceutical Co.

View Profile
Address
6/F, Garden No. 1, Kekai
Guiyang Guizhou 550018
China
Employees -
Website http://www.xinbang.com
Updated 07/08/2019
Guizhou Xinbang Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its business segments include pharmaceutical production and development, medical services, and medicine distribution sectors. Its products include medicines for cardiovascular and cerebrovascular, digestive system, endocrine, blood system, and urinary system diseases.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.